“…This results in smaller effect sizes in SPD samples for endophenotypic measures. For example, one of the most robust ERP biomarkers of schizophrenia, auditory P300 amplitude reduction, appears to be less reliably affected in SPD: Previous studies have shown moderate (Mannan et al, 2001), mild (Niznikiewicz et al, 2000) or non-significant reductions of auditory P300 amplitude (Salisbury et al, 1996; Shin et al, 2010; Trestman et al, 1996). Moreover, familial SPD participants have been reported to be more impaired than non-familial SPD participants on a variety of schizophrenia biomarkers, including smooth pursuit eye movement abnormalities (Thaker et al, 1996), grammatical comprehension errors (Condray & Steinhauer, 1992) and P300 amplitude (Kimble et al, 2000).…”